(Press-News.org) Steven Wilhelm joins a distinguished roster this year with his election as a fellow of the Royal Society of Canada (RSC) Academy of Science. This recognition is the RSC’s highest honor in areas of arts, social sciences, humanities, and science.
“The RSC inducts fellows to help them build a better future in Canada and the world. As a native Canadian, this honor is the pinnacle of what I could have hoped for in my career,” said Wilhelm, the Kenneth and Blaire Mossman Professor in UT’s Department of Microbiology. “It also provides an opportunity for me to work with my collaborators in the United States, Canada, and around the world on science I see as important to understanding the synergies between microorganisms and aquatic systems.”
The RSC’s news announcement detailed its list of 104 fellows for 2024, recognizing achievements across many disciplines following rigorous evaluation and review. Fellows are elected to one of the society’s three academies: the Academy of Arts and Humanities; the Academy of Social Sciences; and the Academy of Science. There are currently 2,524 Fellows.
“The Royal Society of Canada is very proud to welcome today an imposing group of inspiring scholars, artists and creators whose peers have recognized their exceptional contributions to the world of science and culture and to the well-being of Canada,” said RSC President Alain-G. Gagnon. “The impact of their work will continue to be felt in the development of public policies for years to come, while contributing to the well-being of our society.”
For Wilhelm’s selection, the society cited his research in advancing the study of microbes in aquatic systems, including the roles of viruses as drivers of marine and freshwater biogeochemistry, and his contributions in biogeochemistry, molecular ecology, oceanography, and limnology.
They specifically noted his research in how microbes shape their environment and how environmental conditions shape microbial communities, such as factors that control the ecology of toxigenic cyanobacteria in fresh waters, the bioavailability of trace elements in seawater, and the use of molecular tools to characterize microbial community function across aquatic systems.
“I am hoping I can use this newfound honor to shine an even brighter light on our problems with water resources—and how they are fixable,” said Wilhelm. “For my continuing career at UT, it means a new generation of opportunities in research for our students, postdoctoral fellows, and scientific staff.”
Wilhelm and his family will attend the induction ceremony for the 2024 fellows on Friday, November 8, 2024, during the RSC’s Celebration of Excellence and Engagement in Vancouver, British Columbia.
END
UT microbiologist Wilhelm honored as Fellow of the Royal Society of Canada
2024-09-10
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
NCCN Policy Summit explores how to build an inclusive cancer center workplace culture that better serves everybody
2024-09-10
WASHINGTON, D.C. [September 10, 2024] — The National Comprehensive Cancer Network® (NCCN®) held an oncology policy summit today in Washington, D.C., focused on Advancing Diversity, Equity, and Inclusion in the Cancer Workforce. The event featured a keynote address from Tiffany Wallace, PhD, Branch Director, Disparities Research Branch, National Cancer Institute (NCI) Center for Cancer Health Equity. Panel discussions focused on how to establish and prioritize a culture of diversity, equity, inclusion, and belonging and maintain the commitment through a changing policy landscape. A series of ...
Games, puzzles and reading can slow cognitive decline in the elderly — even in those with mild cognitive impairment
2024-09-10
By Ann Kellett, Texas A&M University School of Public Health
The aging process can lead to diminished cognitive functioning for older adults. In addition, about 10 percent of people previously diagnosed with mild cognitive impairment develop Alzheimer’s disease or other forms of dementia every year.
Although a few studies have found that activities such as putting together jigsaw puzzles can protect against cognitive aging, the benefits of these activities in preventing or postponing cognitive ...
An antidiabetic helps the immune system recognize reservoirs of HIV
2024-09-10
Researchers at Université de Montréal’s affiliated hospital research centre, the CRCHUM, say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.
Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral therapy, Canadian researchers say in a new study.
In 2021, a team led by immunologist Petronela Ancuta of Université de Montréal’s affiliated hospital research centre, ...
Department of Energy grant advances clean energy studies
2024-09-10
Dr. Berna Hascakir, professor in the Harold Vance Department of Petroleum Engineering at Texas A&M University, was selected as part of a $17 million grant from the U.S. Department of Energy’s (DOE) Office of Fossil Energy and Carbon Management. The investment will support university-led projects that advance decarbonization and net-zero greenhouse gas emissions.
In partnership with Texas A&M, Texas Tech University, Howard University, and the University at Buffalo, this initiative unites three minority-serving ...
Finding the right path(way) to reduce fat accumulation in the liver
2024-09-10
Using a novel stem cell platform, a team of Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD. The MUSC team was led by Stephen Duncan, Ph.D., SmartState Endowed Chair in Regenerative Medicine at MUSC, and Caren Doueiry, an M.D., Ph.D. candidate in Duncan’s laboratory. The team reports its findings in the International Journal of Molecular Sciences.
Almost a quarter of Americans have MASLD, formerly known as non-alcoholic fatty liver disease. It ...
MicroDicer and MicroGrater make quick work of tumor dissection
2024-09-10
As fascinating as it is to work in a modern biology lab, in many cases a lot of repetitive, detailed work is necessary before the research can start. For example, cancer researchers are now capable of using hundreds or even thousands of small, lab-grown tumor samples – known as organoids – to test multiple cancer therapies, including immunotherapies, at once.
To produce organoids, researchers often need to mince a fresh tumor into small pieces by hand, using scissors to snip, snip, snip the specimen down to submillimeter size. This dissection work is tedious and yet often done by skilled – and usually overqualified ...
Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in patients with ROS1+ non-small cell lung cancer
2024-09-10
(San Diego, Calif.--September 10, 2024, 10:35 a.m. PCT) – The ROS1 tyrosine kinase inhibitor (TKI) taletrectinib demonstrated high overall and intracranial responses, and a favorable safety profile with low incidence of neurologic adverse events in TKI-naive and TKI-pretreated patients with ROS1+ non-small cell lung cancer (NSCLC).
These results were presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer by Dr. Geoffrey Liu, from Princess Margaret Cancer Centre, ...
LUMINOSITY trial demonstrates telisotuzumab vedotin shows durable response in Asian patients with c-Met protein-overexpressing EGFR WT nonsquamous NSCLC
2024-09-10
LUMINOSITY Trial Demonstrates Telisotuzumab Vedotin Shows Durable Response in Asian Patients with c-Met Protein-Overexpressing EGFR WT Nonsquamous NSCLC
(San Diego, Calif.--September 10, 2024 10:35 a.m.) -- The c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an acceptable safety profile in patients of Asian race with c-Met protein-overexpressing, epidermal growth factor receptor (EGFR) wildtype (WT), locally advanced/metastatic nonsquamous non-small cell ...
PM2.5 exposure may affect lung cancer in women who have never smoked
2024-09-10
(San Diego, Calif.--September 10, 2024, 10:35 a.m. PCT) – Recent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may significantly impact lung cancer in women who have never smoked, with notable differences in stage IV diagnoses among EGFR+ patients, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer.
The International Agency for Research on Cancer (IARC) categorized outdoor air pollution and its key component, particulate matter PM2.5, as Group 1 carcinogens in 2013, indicating that they cause lung cancer. Associations between ...
Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC presented at WCLC 2024
2024-09-10
(San Diego, Calif.--September 10, 2024, 10:35 a.m. PCT) A phase 3 study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy and immunotherapy (in combination or sequential), whose tumors highly expressed CEACAM5, is presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer in San Diego, Calf., by Dr. Benjamin Besse of Gustave Roussy, in Paris, France. As previously announced by Sanofi in December 2023, ...